Literature DB >> 16714017

Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed.

Hyoung-Tai Kim1, Il-Sun Kim, Il-Shin Lee, Jean-Pyo Lee, Evan Y Snyder, Kook In Park.   

Abstract

Proliferating single cells were isolated from various CNS regions (telencephalon, diencephalon, midbrain, cerebellum, pons and medulla, and spinal cord) of human fetal cadavers at 13 weeks of gestation and grown as neurospheres in long-term cultures. We investigated whether neural stem cells (NSCs) or progenitors within spheres have specific regional or temporal characteristics with regard to growth, differentiation, and region-specific gene expression, and whether these molecular specifications are reversible. Regardless of regional origin, all of the neurospheres were found to contain cells of different subtypes, which suggests that multipotent NSCs, progenitors or radial glial cells co-exist with restricted neuronal or glial progenitors within the neurospheres. Neurospheres from the forebrain grew faster and gave rise to significantly more neurons than did those from either the midbrain or hindbrain, and regional differences in neuronal differentiation appeared to be sustained during long-term passage of neurospheres in culture. There was also a trend towards a reduction in neuronal emergence from the respective neurospheres over time in culture, although the percentages of neurons generated from cerebellum-derived neurospheres increased dramatically. These results suggest that differences in neuronal differentiation for the various neurospheres are spatially and temporally determined. In addition, the properties of glial fibrillary acidic protein (GFAP)-, glutamate-, and gamma-aminobutyric acid (GABA)-expressing cells derived from neurospheres of the respective CNS regions appear to be regionally and temporally different. Isolated human neurospheres from different CNS compartments expressed distinctive molecular markers of regional identity and maintained these patterns of region-specific gene expression during long-term passage in vitro. To determine the potential of human neurospheres for regional fate plasticity, single spheres from the respective regions were co-cultured with embryonic day 16.5 (E16.5 d) mouse brain slices. Specific cues from the developing mouse brain tissues induced the human neurospheres to express different marker genes of regional identity and to suppress the expression of their original marker genes. Thus, even the early regional identities of human neurospheres may not be irreversible and may be altered by local inductive cues. These findings have important implications for understanding the characteristics of growth, differentiation, and molecular specification of human neurospheres derived from the developing CNS, as well as the therapeutic potential for neural repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714017     DOI: 10.1016/j.expneurol.2006.03.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  28 in total

1.  Evidence for and against regional differences in neural stem and progenitor cells of the CNS.

Authors:  Oren J Becher; Eric C Holland
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

2.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Authors:  Da Yong Lee; Tu-Hsueh Yeh; Ryan J Emnett; Crystal R White; David H Gutmann
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

3.  Generation of spinal motor neurons from human fetal brain-derived neural stem cells: role of basic fibroblast growth factor.

Authors:  Paivi M Jordan; Luis D Ojeda; Jason R Thonhoff; Junling Gao; Darren Boehning; Yongjia Yu; Ping Wu
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

4.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

Review 5.  Neurospheres: a potential in vitro model for the study of central nervous system disorders.

Authors:  Laura da Silva Siqueira; Fernanda Majolo; Ana Paula Bornes da Silva; Jaderson Costa da Costa; Daniel Rodrigo Marinowic
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

6.  Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.

Authors:  Yi-Hsien Chen; Lucy D'Agostino McGowan; Patrick J Cimino; Sonika Dahiya; Jeffrey R Leonard; Da Yong Lee; David H Gutmann
Journal:  Cell Rep       Date:  2015-03-12       Impact factor: 9.423

7.  Direct reprogramming of human neural stem cells by OCT4.

Authors:  Jeong Beom Kim; Boris Greber; Marcos J Araúzo-Bravo; Johann Meyer; Kook In Park; Holm Zaehres; Hans R Schöler
Journal:  Nature       Date:  2009-10-01       Impact factor: 49.962

8.  Neural stem/progenitor cells derived from the embryonic dorsal telencephalon of D6/GFP mice differentiate primarily into neurons after transplantation into a cortical lesion.

Authors:  Iva Prajerova; Pavel Honsa; Alexandr Chvatal; Miroslava Anderova
Journal:  Cell Mol Neurobiol       Date:  2009-08-26       Impact factor: 5.046

9.  Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.

Authors:  Sungju Park; Hyoung-Tae Kim; Seokkwan Yun; Il-Sun Kim; Jiyoon Lee; Il-Shin Lee; Kook In Park
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

10.  Identification of differentially expressed proteins in murine embryonic and postnatal cortical neural progenitors.

Authors:  Lorelei D Shoemaker; Nicholas M Orozco; Daniel H Geschwind; Julian P Whitelegge; Kym F Faull; Harley I Kornblum
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.